Sandy Hook, CT, United States of America

Sanjaya Singh

USPTO Granted Patents = 69 (Patent Applications = 81)

CIPO Patents = 7 (Patent Applications = 55)

EPO Patents = 15 (Patent Applications = 83)

Average Co-Inventor Count = 5.8

ph-index = 12

Forward Citations = 359(Granted Patents)

Forward Citations (Not Self Cited) = 304(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Houston, TX (US) (2009)
Sandy Hook, CO (US) (2016)
Sandy Hook, CT (US) (2011 - 2024)
Blue Bell, PA (US) (2019 - 2024)

Company Filing History:

26 out of 1,536

Boehringer Ingelheim International Gmbh

Janssen Biotech, Inc.

Janssen Pharmaceutica Nv

where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...

Areas of Expertise:

Antibody Targeting

Chimeric Antigen Receptors

Immunoglobulin Single Variable Domains

Biotransportation

T Cell Mediated Immunity

CX3CR1 Binding Polypeptides

Pluripotent Stem Cells

Immunotherapy

Biotherapeutics

Targeted Therapies

Cancer Treatment

Immune Modulation

69 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12460001 - Proteins comprising CD3 antigen binding domains and uses thereof (2025-11-04),

2. 12448449 - Immune targeting molecules and uses thereof (2025-10-21),

3. 12221487 - Nucleic acids encoding CX3CR1-binding polypeptides comprising immunoglobulin single variable domains (2025-02-11),

4. 12180278 - Antibody targeting CD22 and CD79B (2024-12-31),

5. 12134658 - Materials and methods for multidirectional biotransportation in virotherapeutics (2024-11-05),

6. 12129310 - Materials and methods for enhanced linker targeting (2024-10-29),

7. 12103977 - Trispecific antibody targeting CD79b, CD20, and CD3 (2024-10-01),

8. 12077592 - GPRC5D chimeric antigen receptors and cells expressing the same (2024-09-03),

9. 12077585 - Proteins comprising kallikrein related peptidase 2 antigen binding domains and their uses (2024-09-03),

10. 12076413 - Compositions and methods for modulating delta gamma chain mediated immunity (2024-09-03),

11. 12071466 - Anti-human kallikrein-2 (hK2) chimeric antigen receptor (CAR) and methods of use thereof (2024-08-27),

12. 11981932 - Materials and methods for the manufacture of pluripotent stem cells (2024-05-14),

13. 11965024 - Methods and compositions for modulating beta chain mediated immunity (2024-04-23),

14. 11926667 - Bioengineered T cell mediated immunity, materials and other methods for modulating cluster of differentiation IV and/or VIII (2024-03-12),

15. 11897964 - Anti-PSGL-1 antibodies and uses thereof (2024-02-13),

Title: Sanjaya Singh: A Visionary Innovator Reshaping the Future

Introduction: Sanjaya Singh, a brilliant inventor based in Sandy Hook, CT, US, is a true trailblazer in the world of innovation. With a remarkable total of 55 patents to his name, Sanjaya exudes a passion for creating groundbreaking technologies that have the potential to shape a better future for humankind.

Latest Patents: Among his latest patents is the groundbreaking invention of Anti-PSGL-1 antibodies and their uses. These antibodies play a crucial role in immunospecifically binding to PSGL-1, offering innovative solutions in treating disorders associated with T cell proliferation. Additionally, Sanjaya's invention of a compound targeting IL-23A and B-cell activating factor (BAFF) opens new avenues in the field of medicine, paving the way for novel treatments and therapies.

Career Highlights: Sanjaya Singh's illustrious career has seen him contributing his inventive genius to renowned companies such as Boehringer Ingelheim International GmbH and Genentech, Inc. His innovative spirit and dedication to excellence have not only earned him numerous patents but have also positioned him as a key figure in the realm of inventors.

Collaborations: Throughout his career, Sanjaya has collaborated with esteemed professionals in the industry, including Sek Chung Fung and Rachel Rebecca Barrett. These collaborations have not only propelled his innovative endeavors forward but have also fostered a culture of creativity and ingenuity within the teams he has worked with.

Conclusion: Sanjaya Singh's relentless pursuit of innovation and his unwavering commitment to creating transformative technologies solidify his position as a visionary inventor. His impressive array of patents, coupled with his collaborative spirit and impactful career highlights, underscore Sanjaya's status as a truly inspiring figure in the world of inventors, shaping a brighter future through his inventive contributions.

This text is generated by artificial intelligence and may not be accurate.